EVISA Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Clinical and Experimental Allergy

Description
The Official Journal of the British Society for Allergy & Clinical Immunology

 

Status
active
Indexing
ASCA; Biological Abstracts; BIOBASE/Current Awareness in Biological Sciences; Current Contents; Index Medicus; ISI/BIOMED; Science Citation Index
Predecessor
Subject

Source type
Journal
Publisher
ISBN ISSN
0954-7894
E ISSN
1365-2222
First volume
18
Last volume
38+
Publish city
Oxford
Homepage
Description
The journal achieves an excellent balance between clinical and scientific articles and has regular reviews and editorials written by leading authorities in their field. The editors will consider short "hot topic" papers for fast-tracking. In response to the increasing number of quality submissions, since 1996 the journals size has increased by over 30%. Clinical and Experimental Allergy is essential reading for allergy practitioners and research scientists with an interest in allergic diseases and mechanisms. Truly international in appeal, Clinical and Experimental Allergy publishes clinical and experimental observations in disease in all fields of medicine in which allergic hypersensitivity plays a part.

Clinical and Experimental Allergy Reviews is a supplement series publishing the edited proceedings of international meetings and sponsored symposia, position papers, guidelines, special reports, and so on. It is allied to Clinical and Experimental Allergy and included with every subscription to the primary research journal.




Related links:









Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )